Arora S. Project ECHO Hepatitis C Ambulatory Care Quality Improvement in New Mexico through Health Information Technology - Final Report. (Prepared by the University of New Mexico under Grant No. R18 HS018171). Rockville, MD: Agency for Healthcare Research and Quality, 2013.
Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment--Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology 2010 Sep;52(3):1124-33.
Sulkowski M, Wright T, Rossi S, et al. Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy. Clin Pharmacol Ther 2005 Mar;77(3):214-24.
Arora S, O'Brien C, Zeuzem S, et al. Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life. J Gastroenterol Hepatol 2006 Feb;21(2):406-12.